|
||||||||||||||||||
|
|
||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
Questions? Please consult our answers to frequently asked questions at http://www.ebioscience.com/faq. DescriptionThe DJR4-1 monoclonal antibody reacts with human Decoy receptor 2 (DcR2), a transmembrane cell surface protein also known as TRAIL-R4 and TRUNDD. DcR2 has an extracellular TRAIL binding domain and a truncation in the death domain (DD) of its cytoplasmic tail. Along with DcR1, DcR2 binds to TRAIL and inhibits binding of TRAIL to DR4 or DR5 protecting cells from TRAIL-mediated cytotoxicity. DcR2 is expressed in many normal human tissues at low levels, but not in most tumors. Overexpression of DcR2 attenuates TRAIL-induced apoptosis. Applications ReportedFor research use only, not for diagnostic or therapeutic use. The DJR4-1 antibody has been reported for use in flow cytometric analysis. Applications TestedThe DJR4-1 antibody has been tested by flow cytometric analysis of DcR2/293 transient transfected cells. This can be used at less than or equal to 1 μg per million cells in a 100 μl total staining volume. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest. Related ProductsCat. 11-4317 Streptavidin-FITC (Fluorescein isothiocyanate) Cat. 12-4317 Streptavidin-PE (Phycoerythrin) Cat. 17-4317 Streptavidin Allophycocyanin (SA-APC) Cat. 13-4714 Biotin Mouse IgG1, K Isotype Control |
|||||||||||||||||||||||||||||||||||||||||||||
![]() |
![]() |
|
Copyright © 2000-2008 eBioscience, Inc. Product For Research Use Only: Not for further distribution without written consent. |